Identification of Potential Protein Targets in Extracellular Vesicles Isolated from Chemotherapy-Treated Ovarian Cancer Cells
Despite the ongoing clinical trials and the introduction of novel treatments over the past few decades, ovarian cancer remains one of the most fatal malignancies in women worldwide. Platinum- and paclitaxel-based chemotherapy is effective in treating the majority of patients with ovarian cancer. How...
Main Authors: | Chia-Yi Chan, Yi-Chun Ni, Hieu Duc Nguyen, Yung-Fu Wu, Kuen-Haur Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/9/469 |
Similar Items
-
Extracellular vesicles of Bifidobacterium longum reverse the acquired carboplatin resistance in ovarian cancer cells via p53 phosphorylation on Ser15
by: Yun‐Long Fan, et al.
Published: (2024-06-01) -
Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
by: Polina V. Shnaider, et al.
Published: (2023-02-01) -
Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
by: Gerrit Hugendieck, et al.
Published: (2023-07-01) -
Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells
by: Sinforosa Gagliardi, et al.
Published: (2024-03-01) -
Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment
by: Jill Nehrbas, et al.
Published: (2020-02-01)